Literature DB >> 15043193

Matrix metalloproteinaes and bone metastasis.

R Daniel Bonfil1, Pamela Osenkowski, Rafael Fridman, Michael L Cher.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15043193     DOI： 10.1007/978-1-4419-9129-4_8

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  4 in total

1.  Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone.

Authors:  Jeffry S Nyman; Conor C Lynch; Daniel S Perrien; Sophie Thiolloy; Elizabeth C O'Quinn; Chetan A Patil; Xiaohong Bi; George M Pharr; Anita Mahadevan-Jansen; Gregory R Mundy
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

Review 2.  Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes.

Authors:  Juan R Cubillos-Ruiz; Melanie Rutkowski; Jose R Conejo-Garcia
Journal:  Cell Cycle       Date:  2010-01-26       Impact factor: 4.534

3.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.

Authors:  Xin Lu; Qiongqing Wang; Guohong Hu; Catherine Van Poznak; Martin Fleisher; Michael Reiss; Joan Massagué; Yibin Kang
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

4.  Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.

Authors:  R Daniel Bonfil; Zhong Dong; J Carlos Trindade Filho; Aaron Sabbota; Pamela Osenkowski; Sanaa Nabha; Hamilto Yamamoto; Sreenivasa R Chinni; Huiren Zhao; Shahriar Mobashery; Robert L Vessella; Rafael Fridman; Michael L Cher
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.